<DOC>
	<DOCNO>NCT01304290</DOCNO>
	<brief_summary>Our objective study determine implement glucose/insulin clamp ( GICT ) cadaveric organ donor : - Prevent hyperglycaemia - Drop inflammatory cytokine response brain death minimum 6 hour therapy GICT prior organ procurement . - Assess organ ( heart , liver , pancreas kidney ) survival one year post-transplant - Assess graft function evaluating : - Liver : post-transplant liver function score ( PTLF ) - Kidney : graft function define UNOS ( immediate graft function IGF , slow graft function SGF delay graft function DGF - Pancreas : 7 day post-transplant insulin requirement , C-peptide C-RP level day one seven post-transplantation</brief_summary>
	<brief_title>Glucose/Insulin Clamp Solid Organ Transplant ( Liver , Kidney , Pancreas Heart ) Cadaveric Donors</brief_title>
	<detailed_description />
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Pancrelipase</mesh_term>
	<criteria>Donors must 18 year age Brain death donor Getting consent prior specific protocol procedure Transplant Quebec regulation . Inability obtain research consent Time interval start study crossclamping less 6 hour . No solid organ retrieve transplantation Diagnosed Type 1 Diabetes Donor uncontrolled serum blood glucose level ( 10 mmol/L ) time inclusion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>inflammatory process</keyword>
	<keyword>hyperglycaemia</keyword>
	<keyword>inflammatory cytokine response</keyword>
	<keyword>organ survival</keyword>
	<keyword>hyperinsulinemic clamp</keyword>
</DOC>